



One of the pressing problems 
of modern cardiology is the study 
of the etiological and risk factors 
for SCD. Arrhythmias, which in 
most cases correlate with signs 
of myocardial hypertrophy, are 
important for its occurrence. 
The most common cause of LVH 
is hypertension. However, an 
equally important trigger mech-
anism for malignant arrhythmias 
is CHD.
In CHD, myocardium is af-
fected; metabolic processes and 
energy metabolism in cardiomy-
ocytes are disrupted, which in 
turn leads to arrhythmias [1].
LVH is known to be con-
sidered as an independent risk 
factor for cardiovascular compli-
cations (myocardial infarction, 
heart failure (HF), arrhythmias, 
etc.) [2]. Among the mechanisms 
of the development of LVH may 
be considered an episode of hy-
poxia and ischemia, which in 
turn leads to the development 
of post-ischemic cardiomyocyte 
dysfunction and an increase in 
energy deficiency in them [2].
Studies have shown that there 
is some pattern between the mass 
of the left ventricle (LV) myocar-
dium and the occurrence of car-
diovascular catastrophes, includ-
ing SCD. It has been proved that 
the myocardial need for oxygen 
increases and its ectopic activity 
increases with LVH [3].
It is known that in concentric 
LVH the thickness of the walls 
of the myocardium increases and 
the volume of the cavity of the 
LV decreases, while in the eccen-
tric, on the contrary, the normal 
thickness of the walls of the LV 
decreases and the volume of its cavity increases. Literary evidence 
indicates that concentric LVH is associated with the highest risk 
of cardiovascular complications and the worst prognosis [4].
Studies have shown that the larger the LV myocardial mass 
index (LV MMI), the greater the size of the LA. It is proved that 
with increasing size of LA for every 5 mm the relative risk of 
atrial fibrillation increases 4 times [5].
Not all arrhythmias are equally significant for the prog-
nosis of the patient’s disease and life. In this regard, the clin-
ical and prognostic classification of arrhythmias and cardiac 
conduction disorders, depending on their severity, is of some 
clinical importance for predicting the occurrence of various 
cardiovascular complications and their potential for preven-
tion [6].
The literature describes the importance of LVH in the devel-
opment of cardiac arrhythmias, which in turn lead to cases of 
SCD. However, it should be noted that there are insufficient re-
ports on the features of the types 
and degrees of LVH, dilatation of 
the LA, which would most likely 
lead to malignant arrhythmias.
The purpose of the study was 
to investigate the possible effects 
of different types and degrees of 
LVH and LA dilatation on the 
development of malignant ar-
rhythmias in arterial hyperten-
sion, depending on the presence 
or absence of CHD.
2. Material and methods
The study was conducted at 
the Vinnytsa Regional Clinical 
Medical Diagnostic Center for 
Cardiovascular Pathology du- 
ring 2014–2017.
The criteria for inclusion in 
the study were patients with hy-
pertension, various DRCH with 
or without CHD. Exclusion cri-
teria were acute coronary syn-
drome, HFof IV functional class 
(FC) according to NYHA classi-
fication, presence of permanent 
atrial fibrillation, previously di-
agnosed idiopathic cardiomyop-
athies, myocarditis, severe kidney 
disease, liver, lung, and neoplasm. 
The study design included an 
assessment of the effect of car-
diac remodelling, the degree of 
LVH, and the degree of LA dila-
tion on the development of ma-
lignant DRCH. 78 patients were 
examined, including 47 men and 
31 women, with an average age 
(62.18±0.64) years. Systolic blood 
pressure was, on average, deter-
mined (154.97±2.20) mm Hg. art., 
diastolic blood pressure – (90.18± 
±1.91) mm Hg. Art.
The study was conducted 
according to basic bioethical 
standards Helsinki Declaration 
of the World Medical Association on Ethics principles of scien-
tific and medical research as amended (2008), Universal Dec-
laration of Bioethics and Human Rights (1997), Convention 
Council of Europe for Human Rights and Biomedicine (1997).
The duration of hypertension in average was 12.46± 
±2.66 years, CHD – 7.35±0.62 years. HF of II FC according to 
NYHA classification was determined in 62 (79.49 %), III FC – 
in 16 (20.51 %) patients. Patients were divided into two groups. 
The first group (n=40) consisted of patients with hyper-
tension and a variety of DRCH, but without existing CHD. 
The second group (n=38) – with hypertension and available 
DRCH and CHD. In each group, there were malignant rhythm 
and conduction disorders. The control group consisted of 
20 healthy people.
The patients underwent a standard comprehensive clinical 
laboratory and instrumental examination: ECG in 12 conven-
tional leads, blood lipid spectrum, blood glucose, biochemical 
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for its occurrence. The most common cause of left ventricu-
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analysis of blood, Echocardiography in M- and B-modes, Holter 
ECG monitoring, 6-minute stroke test angina or HF.
Determined the types of LV remodelling according to 
Genau (1992), and the degrees of LVH by V. Denesiuk, O. Den-
esiuk (Table 1) [6, 7].
Table 1
Criteria for the diagnosis of degrees of left ventricular 
hypertrophy in cardiovascular diseases according to 
Echocardiography






Thickness of  
the interventricular 
septum, сm
In healthy people male ≤110 male ≤ 1.0
woman ≤ 95 woman ≤ 0.9
I (initial) male 111–170 male 1.01–1.19
woman 96–160 woman 0.91–1.15
II (moderate) male 171–205 male 1.20–1.34
woman 161–190 woman 1.16–1.29
III (significant) male ≥205 male ≥1.35 
woman ≥191 woman ≥1.30 
Note: 1 – in cases where the parameters of LV MMI and the thickness of 
the interventricular septum (TIVS) are different and do not correspond 
to the specified degree of LVH, as a basis, it is advisable to take LV MMI, 
on which to determine its degree of expression; 2 – LV MMI is normal, 
and the index of TIVS corresponds to the II degree of LVH, then we expose 
the I degree of LVH
Along with this used the proposed prof. Denesiuk VI et al. 
criteria for the diagnosis of the degree of dilatation of LA [6]. 
So, the I degree of (initial) dilatation of the LA corresponded 
to 4.0–4.4 cm, the II (moderate) degree – 4.5–5.0 cm, the III 
(significant) degree – ≥5.1 cm.
Professor Denesiuk V.I. published an improved clini-
cal-prognostic classification of life-threatening arrhythmias 
and heart blockade [2] in 1999 and in 2015 [6]. Thus, malig-
nant DRCH included ventricular extrasystole 3–5 gradations 
according to Laun, complete AV blockade with syncopal states, 
ventricular paroxysmal tachycardia (especially “pyruvic tachy-
cardia”) with increasing disorders of hemodynamic, sinus node 
weakness syndrome, QT prolonged syndrome, Brugada syn-
drome, and idioventricular rhythm. 
All data obtained from the study were processed using 
SPSS software by methods of variational statistics minus the 
mean M, the standard deviation S, the mean error of the mean 
m, the confidence criterion t, the confidence value p. The 
difference at p<0.05 was considered statistically significant. 
The investigated values  are given in the form (M±m). Pairwise 
group comparisons were performed using the non-parametric 
Mann-Whitney method.
3. Results
Among patients of group I, without CHD, 5 people (12.5 %) 
had grade I of hypertension, 25 people (62.5 %) had grade II, 
10 people (25 %) had grade III of hypertension. There was no 
significant difference between of hypertension rates in group II 
patients (with CHD). Myocardial infarction occurred in 3 (7.89 %) 
patients of group II. Acute damage of cerebral circulation was 
anamnestic manifested in 1 (2.5 %) patient of group I and in 
2 (5.26 %) – group II.
Each group was further divided into two subgroups depend-
ing on the presence of malignant arrhythmias. Thus, in group I 
(without CHD) malignancies occurred in 18 (45 %) patients 
who did not have a significant difference depending on the 
indicators of pressure, degrees and duration of hypertension. 
Malignant DRCH occurred in 19 (50 %) patients of group II 
(with CHD), but significantly (p> 0.05) occurred more fre-
quently among patients with stable angina or existing HF of FC 
III, as confirmed by other authors [8]. However, they also had 
no significant difference depending on the indices of pressure, 
degrees and duration of hypertension, duration of CHD, anam-
nestic myocardial infarction and acute damage to the cerebral 
circulation. The second degree of hypertension was prevalent 
among all patients.
Echocardiography was performed on all patients. Com-
parative analysis was subjected to a control group (healthy 
patients) with each group of patients with hypertension. The 
likelihood of difference (p>0.05) of LV MMI values, LA size, 
volume systolic and diastolic indices, and ejection fraction 
(EF) of patients without CHD and CHD compared with 
healthy people and the probability of difference (p≤0.01) 
values of the interventricular and posterior walls of the LV 
compared with healthy people. However, no validity was found 
between and without cohorts of patients with CHD, suggest-
ing the same development of LVH in patients in both cohorts, 
which was not dependent on the development of changes in 
CHD. In addition, no significant differences were found in 
the comparative characteristics of patients with malignant 
arrhythmias in patients in both groups. The results of echo-
cardiography indicated the development of different types of 
LVH with preserved systolic heart function. Such changes lead 
to impaired cardiac muscle relaxation and increase myocardial 
stiffness, promoting the development of HF and capable of 
provoking the onset of DRCH.
The conducted analysis of the Echocardiography study 
allowed dividing the patients by types of heart remodelling ac-
cording to Genau, degrees of LVH by V. Denesiuk, O. Denesiuk 
and the degree of dilatation of LA of both groups and depend-
ing on the available malignant arrhythmias. No significant 
differences were found in patients from both groups and when 
comparing patients with malignant DRCH. However, it should 
be noted that all patients were dominated by concentric hyper-
trophy for Genau, which confirms a higher incidence of DRCH. 
This type of hypertrophy of the LV occurs as a compensatory 
mechanism, ensuring normal circulation with elevated blood 
pressure. Over time, the compensatory properties weaken, 
the incidence of HF increases, and the risk of SCD increases 
significantly [9]. The mean was (77.19±2.49) % and eccentric 
hypertrophy was (15.5±3.25) %. When comparing the rates of 
VH by V. Denesiuk, O. Denesiuk, the patients of both groups 
showed a predominance of the initial degree of LVH, which 
was already accompanied by the development of DRCH and 
the initial degree of dilatation of LA, In comparison of both 
groups with malignant arrhythmias – a moderate degree of 
LVH and a significant degree of predominance p>0.05 there was 
a more frequent occurrence of LA dilatation in patients with 
hypertension in combination with CHD and existing malignant 
DRCH, which can be caused by the increase of paroxysmal 
and persistent forms of atrial fibrillation, which according to 
V. I. Denesiuk was not classified as malignant.
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4. Discussion and conclusions
Comparative characteristics of the types of malignant 
DRCH in two groups were conducted. Thus, the most common 
type of malignant DRCH were ventricular extrasystoles 3–5 gra- 
dations according to Laun, which occurred significantly 
(p>0.05) more frequently in patients of group II (with coronary 
heart disease). In addition, in second group, 1 (2.63 %) patient 
experienced QT prolongation on the background of amiodarone 
administration and 2 (5.26 %) patients experienced sinus node 
weakness syndrome, which was absent in group I patients. It 
should be noted that all DRCH in both groups occurred only 
with hypertrophic LVH and the initial stages of LVH and dila-
tation of LA. The obtained data are confirmed by other authors 
[10], who indicate an increase in the frequency of QT prolonga-
tion on the background of arrhythmic drugs, with an increase 
in the degree of LVH.
In patients with hypertension and coronary heart disease, 
malignant rhythm and conduction of the heart are significantly 
more likely to occur with a greater degree of functional class of 
stable angina and heart failure, and regardless of the duration of 
coronary heart disease and hypertension.
The highest frequency of various malignant disorders oc-
curs in concentric left ventricular hypertrophy, regardless of the 
presence of coronary heart disease.
Malignant abnormalities of rhythm and conduction of the 
heart occur even with the initial degree of left ventricular hy-
pertrophy and left atrial dilatation and increase with hypertro-
phy in patients in both groups.
Among the malignant disorders in the overwhelming num-
ber occur ventricular extrasystoles 3–5 gradations according to 
Laun in both groups, and significantly more often in combina-
tion with coronary heart disease, contributes to the develop-
ment of the probability of acquired QT syndrome against the 
background of taking amiodarone, which may in turn develop 
malignant and fatal heart rhythm disorders.
Coronary heart disease may be an additional provocative 
risk factor for malignant heart rhythm disorders.
The proposed determination of the degree of left ventricular 
hypertrophy and left atrial dilatation in patients with hyperten-
sion allows to evaluate in more detail and specifically the cardi-
ac remodelling and possibly to determine the gradual regression 
of left ventricular hypertrophy on the background of treatment.
Taking into account the revealed data on the dependence 
of the development of malignant arrhythmias on the func-
tional class of stable angina and heart failure, it is necessary 
to evaluate the influence of indicators of lipid metabolism 
and the degree of damage of the coronary bed atherosclerotic 
process on the development of malignant disorders of rhythm 
and conduction.
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